BrightRed 780 Anti-Human CD127/IL-7RA Antibody[A019D5]

Human peripheral blood lymphocytes are stained with FITC Anti-Human CD3 Antibody and  BrightRed 780 Anti-Human CD127/IL-7RA Antibody (Left). Lymphocytes are stained with FITC Anti-Human CD3 Antibody and BrightRed 780 Mouse IgG1, κ Isotype Control (Right).

Human peripheral blood lymphocytes are stained with FITC Anti-Human CD3 Antibody and BrightRed 780 Anti-Human CD127/IL-7RA Antibody (Left). Lymphocytes are stained with FITC Anti-Human CD3 Antibody and BrightRed 780 Mouse IgG1, κ Isotype Control (Right).

Catalog Number:MAB1152S
Conjugate:BrightRed 780
Size:100Tests
Concentration:5 μL/Test
Host:Mouse
Isotype:Mouse IgG1, κ
Clone:Monoclonal
Reactivity:Human
Applications:Each lot of this antibody is quality control tested by flow cytometric analysis. <b style="color:#0070ca">The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood).</b> Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Form:Liquid
Synonyms:IL7R;CD127;CDW127;IL-7R-alpha;IL7RA;ILRA

CD127 is a 60-90 kD type I transmembrane glycoprotein also known as IL-7 receptor α chain or IL-7Rα. It forms a heterodimer with the common γ chain (γc or CD132) which is shared with the receptors for IL-2, IL-4, IL-9, IL-13, IL-15, and IL-21. CD127 is expressed on immature B cells through early pre-B stage cells, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, and bone marrow stromal cells. CD127 has been reported to be a useful marker for identifying memory and effector T cells. Studies have shown that CD127 expression is down-modulated on Treg cells. It can be used as a marker for differentiation of Treg and conventional T cells. The ligation of IL-7 with its receptor is important for stimulation of mature and immature T cells as well as immature B cell proliferation and development.

Applications

Each lot of this antibody is quality control tested by flow cytometric analysis. <b style="color:#0070ca">The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood).</b> Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.

Target Background

CD127 is a 60-90 kD type I transmembrane glycoprotein also known as IL-7 receptor α chain or IL-7Rα. It forms a heterodimer with the common γ chain (γc or CD132) which is shared with the receptors for IL-2, IL-4, IL-9, IL-13, IL-15, and IL-21. CD127 is expressed on immature B cells through early pre-B stage cells, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, and bone marrow stromal cells. CD127 has been reported to be a useful marker for identifying memory and effector T cells. Studies have shown that CD127 expression is down-modulated on Treg cells. It can be used as a marker for differentiation of Treg and conventional T cells. The ligation of IL-7 with its receptor is important for stimulation of mature and immature T cells as well as immature B cell proliferation and development.

Synonyms:IL7R;CD127;CDW127;IL-7R-alpha;IL7RA;ILRA

Storage

This product can be stored at 2-8°C for 24 months. Please protected from prolonged exposure to light and do not freeze.

Buffer

Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer.

Human peripheral blood lymphocytes are stained with FITC Anti-Human CD3 Antibody and BrightRed 780 Anti-Human CD127/IL-7RA Antibody (Left). Lymphocytes are stained with FITC Anti-Human CD3 Antibody and BrightRed 780 Mouse IgG1, κ Isotype Control (Right).

No documents available.